• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状旁腺激素和碱性磷酸酶与透析治疗的慢性肾脏病儿童的骨转换和矿化的关系:年龄、性别和种族的影响。

Association of parathormone and alkaline phosphatase with bone turnover and mineralization in children with CKD on dialysis: effect of age, gender, and race.

机构信息

Laboratório de Investigação Médica 16, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.

Faculdade Pernambucana de Saúde, Recife, Brazil.

出版信息

Pediatr Nephrol. 2020 Jul;35(7):1297-1305. doi: 10.1007/s00467-020-04499-2. Epub 2020 Mar 10.

DOI:10.1007/s00467-020-04499-2
PMID:32157445
Abstract

BACKGROUND

Studies investigating bone histology in children with chronic kidney disease (CKD) are scarce.

METHODS

Forty-two patients, mean age 11.3 ± 4.3 years with stage 5 CKD on dialysis, underwent double tetracycline labeling bone biopsy and the relationship between clinical features, biochemical markers, and bone densitometry (DXA) was investigated.

RESULTS

Low bone turnover was present in 59% of patients, abnormal mineralization in 29%, and low bone volume in 7%. Higher bone formation rate was found in non-Caucasian patients, whereas abnormal mineralization occurred in older and shorter children. We found no impact of gender and etiology of renal disease in our population. Parathormone (PTH) and alkaline phosphatase (AP) showed positive associations with bone turnover. ROC curve analysis showed a fair performance of biomarkers to predict TMV status. PTH < 2 times ULN independently associated with low bone turnover (RR 5.62, 95% CI 1.01-31.24; p = 0.049), in a model adjusted for race, calcitriol dosage, and calcium. It was also associated with abnormal mineralization (RR 1.35, 95% CI 1.04-1.75; p = 0.025), in a model adjusted for BMD scores, AP, age, and calcitriol. PTH and AP significantly predicted turnover and mineralization defect, although with low specificity and sensitivity, reaching a maximum value of 64% and 67%, respectively.

CONCLUSIONS

While PTH and AP were associated with turnover and mineralization, we recognize the limitation of their performance to clearly distinguish high from low/normal bone turnover and normal from abnormal mineralization. Our results reinforce the need to expand knowledge about renal osteodystrophy in pediatric population through prospective bone biopsy studies. Graphical abstract.

摘要

背景

目前针对慢性肾脏病(CKD)患儿骨组织学的研究较为匮乏。

方法

42 名平均年龄为 11.3±4.3 岁的处于透析阶段 5 的 CKD 患儿接受了双四环素标记骨活检,我们对其临床特征、生化标志物与骨密度(DXA)之间的关系进行了研究。

结果

59%的患者表现为低转换型骨病,29%的患者表现为骨矿化异常,7%的患者表现为低骨量。非白种人患者的骨形成率较高,而骨矿化异常在年龄较大和身材较矮小的儿童中更为常见。我们的研究人群中,性别和肾脏疾病的病因对结果没有影响。甲状旁腺激素(PTH)和碱性磷酸酶(AP)与骨转换呈正相关。ROC 曲线分析显示,生物标志物对预测 TMV 状态有一定的作用。在校正种族、骨化三醇剂量和钙后,PTH<2 倍 ULN 与低转换型骨病独立相关(RR 5.62,95%CI 1.01-31.24;p=0.049),且与骨矿化异常相关(RR 1.35,95%CI 1.04-1.75;p=0.025)。在校正 BMD 评分、AP、年龄和骨化三醇后,PTH 和 AP 显著预测了骨转换和骨矿化缺陷,尽管特异性和敏感性较低,分别达到 64%和 67%。

结论

虽然 PTH 和 AP 与骨转换和骨矿化相关,但我们认识到它们的性能存在局限性,无法明确区分高转换和低/正常转换以及正常和异常矿化。我们的研究结果强调了通过前瞻性骨活检研究来增加对儿科人群肾性骨营养不良认识的必要性。

相似文献

1
Association of parathormone and alkaline phosphatase with bone turnover and mineralization in children with CKD on dialysis: effect of age, gender, and race.甲状旁腺激素和碱性磷酸酶与透析治疗的慢性肾脏病儿童的骨转换和矿化的关系:年龄、性别和种族的影响。
Pediatr Nephrol. 2020 Jul;35(7):1297-1305. doi: 10.1007/s00467-020-04499-2. Epub 2020 Mar 10.
2
Value of the new bone classification system in pediatric renal osteodystrophy.新的骨分类系统在儿科肾性骨营养不良中的价值。
Clin J Am Soc Nephrol. 2010 Oct;5(10):1860-6. doi: 10.2215/CJN.01330210. Epub 2010 Jul 15.
3
Bone alkaline phosphatase isoforms in hemodialysis patients with low versus non-low bone turnover: a diagnostic test study.骨转换率低与非低的血液透析患者的骨碱性磷酸酶同工型:一项诊断试验研究
Am J Kidney Dis. 2015 Jul;66(1):99-105. doi: 10.1053/j.ajkd.2015.02.323. Epub 2015 Apr 2.
4
Bone histomorphometry and indicators of bone and mineral metabolism in wait-listed dialysis patients.等待透析患者的骨组织形态计量学以及骨与矿物质代谢指标
Clin Nephrol. 2016 Mar;85(3):127-34. doi: 10.5414/CN108709.
5
Bone turnover markers predict type of bone histomorphometry and bone mineral density in Asian chronic haemodialysis patients.骨转换标志物可预测亚洲慢性血液透析患者的骨组织形态计量学类型和骨密度。
Nephrology (Carlton). 2020 Feb;25(2):163-171. doi: 10.1111/nep.13593. Epub 2019 May 2.
6
Changes in Bone Histomorphometry after Kidney Transplantation.肾移植后骨组织形态计量学的变化。
Clin J Am Soc Nephrol. 2019 Jun 7;14(6):894-903. doi: 10.2215/CJN.09950818. Epub 2019 May 14.
7
Bone histomorphometry in children prior to commencing renal replacement therapy.开始肾脏替代治疗前儿童的骨组织形态计量学
Pediatr Nephrol. 2008 Sep;23(9):1523-9. doi: 10.1007/s00467-008-0838-6. Epub 2008 May 15.
8
Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients.骨标志物在血液透析患者低转换型骨营养不良诊断中的应用
Nephrol Dial Transplant. 1998 Sep;13(9):2294-302. doi: 10.1093/ndt/13.9.2294.
9
[Diagnostic accuracy study comparing total alkaline phosphatase with intact parathyroid hormone 1-84 for the diagnosis of high turnover renal osteodystrophy in chronic renal failure on hemodialysis].[比较总碱性磷酸酶与完整甲状旁腺激素1-84对血液透析慢性肾衰竭患者高转换型肾性骨营养不良诊断的诊断准确性研究]
Medwave. 2014 Sep 3;14(8):e6014. doi: 10.5867/medwave.2014.08.6014.
10
Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis.透析治疗的慢性肾脏病患者骨转换标志物和骨组织学的诊断准确性。
Am J Kidney Dis. 2016 Apr;67(4):559-66. doi: 10.1053/j.ajkd.2015.06.023. Epub 2015 Aug 25.

引用本文的文献

1
Adynamic bone disorder in chronic kidney disease: meta-analysis and narrative review of potential biomarkers as diagnosis and therapeutic targets.慢性肾脏病中的动力缺失性骨病:作为诊断和治疗靶点的潜在生物标志物的荟萃分析与叙述性综述
Ren Fail. 2025 Dec;47(1):2530162. doi: 10.1080/0886022X.2025.2530162. Epub 2025 Jul 16.
2
Update on the role of bone turnover markers in the diagnosis and management of osteoporosis: a consensus paper from The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), International Osteoporosis Foundation (IOF), and International Federation of Clinical Chemistry and Laboratory Medicine (IFCC).骨转换标志物在骨质疏松症诊断和管理中的作用更新:来自欧洲骨质疏松症、骨关节炎和肌肉骨骼疾病临床与经济学会(ESCEO)、国际骨质疏松症基金会(IOF)以及国际临床化学和检验医学联合会(IFCC)的共识文件。
Osteoporos Int. 2025 Apr;36(4):579-608. doi: 10.1007/s00198-025-07422-3. Epub 2025 Mar 28.
3
Carotid intima-media thickness, fibroblast growth factor 23, and mineral bone disorder in children with chronic kidney disease.儿童慢性肾脏病患者的颈动脉内膜中层厚度、成纤维细胞生长因子 23 与矿物质骨代谢紊乱。
BMC Nephrol. 2024 Oct 21;25(1):369. doi: 10.1186/s12882-024-03771-z.
4
Chronic kidney disease mineral bone disorder in childhood and young adulthood: a 'growing' understanding.儿童及青年期慢性肾脏病-矿物质和骨异常:逐渐深入的认识
Pediatr Nephrol. 2024 Mar;39(3):723-739. doi: 10.1007/s00467-023-06109-3. Epub 2023 Aug 25.
5
Effects of Primary Kidney Disease Etiology on Renal Osteodystrophy in Pediatric Dialysis Patients.原发性肾脏病病因对小儿透析患者肾性骨营养不良的影响。
JBMR Plus. 2022 Apr 8;6(4):e10601. doi: 10.1002/jbm4.10601. eCollection 2022 Apr.
6
Bone and Mineral Disorder in Renal Transplant Patients: Overview of Pathology, Clinical, and Therapeutic Aspects.肾移植患者的骨与矿物质紊乱:病理学、临床及治疗方面概述
Front Med (Lausanne). 2022 Mar 10;9:821884. doi: 10.3389/fmed.2022.821884. eCollection 2022.
7
Natural History of Bone Disease following Kidney Transplantation.肾移植后骨骼疾病的自然史。
J Am Soc Nephrol. 2022 Mar;33(3):638-652. doi: 10.1681/ASN.2021081081. Epub 2022 Jan 19.
8
Brazilian guidelines for chronic kidney disease-mineral and bone metabolism disorders in children and adolescents.巴西儿童和青少年慢性肾脏病 - 矿物质和骨代谢紊乱指南。
J Bras Nefrol. 2021 Dec 3;43(4 Suppl 1):680-692. doi: 10.1590/2175-8239-JBN-2021-S114. eCollection 2021.
9
From the Old, the Best: Parathyroidectomy in the Management of Soft-Tissue and Vascular Calcification in Patients with Chronic Renal Disease.取其精华:甲状旁腺切除术在慢性肾病患者软组织和血管钙化管理中的应用
Case Rep Nephrol. 2021 Nov 9;2021:9985308. doi: 10.1155/2021/9985308. eCollection 2021.
10
Paracrine Kynurenic Pathway Activation in the Bone of Young Uremic Rats Can Antagonize Anabolic Effects of PTH on Bone Turnover and Strength through the Disruption of PTH-Dependent Molecular Signaling.旁分泌犬尿氨酸途径在年轻尿毒症大鼠骨骼中的激活可通过破坏 PTH 依赖性分子信号转导来拮抗 PTH 对骨代谢和骨强度的合成代谢作用。
Int J Mol Sci. 2021 Jun 18;22(12):6563. doi: 10.3390/ijms22126563.